Acupressure therapy for pregnancy-related nausea and vomiting: A comprehensive mini review

Nausea and vomiting during pregnancy, commonly referred to as morning sickness, affects approximately 80% of pregnant women, typically manifesting between the 4th and 16th weeks of gestation. While conventional pharmacological treatments exist, concerns regarding their safety profiles and potential adverse effects have prompted increased interest in non-pharmacological alternatives. Acupressure therapy, a traditional complementary medicine technique involving the application of targeted pressure to specific anatomical points, has emerged as a promising intervention for managing pregnancy-related nausea and vomiting. This mini review synthesizes current evidence regarding the effectiveness of acupressure, particularly focusing on stimulation of the P6 (Pericardium 6 or Neiguan) acupoint located on the wrist, in alleviating symptoms of morning sickness among pregnant women. A comprehensive analysis of recent studies reveals consistent evidence supporting acupressure's efficacy in reducing both the frequency and severity of nausea and vomiting episodes during early pregnancy. The reviewed literature demonstrates that acupressure intervention results in statistically significant improvements in morning sickness scores, with reductions ranging from 50-70% in symptom severity across multiple studies. The technique shows particular promise due to its non-invasive nature, absence of significant side effects, ease of application, and cost-effectiveness. Various delivery methods, including manual pressure application and acupressure wristbands, have shown therapeutic benefits. The evidence strongly supports acupressure as a safe, accessible, and effective non-pharmacological intervention for managing pregnancy-related nausea and vomiting. Given its favorable safety profile and practical applicability in both clinical and community settings, acupressure represents a valuable therapeutic option for healthcare providers managing pregnant women experiencing morning sickness, potentially reducing reliance on pharmacological interventions and improving maternal quality of life during early pregnancy.